Thyrotoxicosis- Review
Abstract
The thyroid hormone is the one the major hormone that regulates body metabolism, growth, reproduction, and neuronal development. One of the common presentations of thyroid dysfunction is thyrotoxicosis. Essentially, inappropriately higher amounts of circulating thyroid hormone results in excessive thyroid hormone action at the tissue level which is clinically manifested as Thyrotoxicosis. Thyrotoxicosis results from hypothalamic-pituitary-thyroid axis dysfunction that results in excessive production of thyroid hormone. Hyperthyroidism is a subset form of thyrotoxicosis wherein there is a high amount of production of thyroid hormone(s) by the thyroid. The prevalence of hyperthyroidism is 1.3% in the USA and occurs more commonly in the female population (2%) than the male population (0.2%) (Sharma and Stan 2019).
Downloads
References
• Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell’ Unto E, et al. (1998) Relation between therapy for hyperthyroidism and the course of Graves’
ophthalmopathy. N Engl J Med 338:73-8
• Cooper DS. (2005) Antithyroid drugs. N Engl J Med 352:905-17.
• Cappa M, Bizzarri C, Crea F.(2010) Autoimmune thyroid diseases in children. J Thyroid Res 2011:675703.
• Hubbard, J. G. H. (2011) ‘Thyrotoxicosis and thyroiditis’, Surgery. Elsevier Ltd, 29(9), pp. 440–445. doi: 10.1016/j.mpsur.2011.06.003.
• Hudzik, B. and Zubelewicz-Szkodzinska, B. (2016) ‘Antithyroid drugs during breastfeeding’, Clinical Endocrinology, 85(6), pp. 827–830. doi: 10.1111/cen.13176.
• John, M., Sundrarajan, R. and Gomadam, Ss. (2015) ‘Anti-thyroid drugs in pediatric Graves′ disease’, Indian Journal of Endocrinology and Metabolism, 19(3), p.
doi: 10.4103/2230-8210.152766.
• Palit TK, Miller CC 3rd, Miltenburg DM. (2000) The efficacy of thyroidectomy for Graves’ disease: A meta-analysis. J Surg Res 90:161-5.
• Sharma, A. and Stan, M. N. (2019) ‘Thyrotoxicosis: Diagnosis and Management’, Mayo Clinic Proceedings. Mayo Foundation for Medical Education and Research, 94(6), pp. 1048–1064. doi: 10.1016/j.mayocp.2018.10.011.
• Taylor, P. N. et al. (2018) ‘Global epidemiology of hyperthyroidism and hypothyroidism’, Nature Reviews Endocrinology. Nature Publishing Group, 14(5), pp. 301–316. doi: 10.1038/nrendo.2018.18.
• Thadani, H., Deacon, A. and Peters, T. (2000) ‘Clinical review: Diagnosis and Management of Porphyria’, British Medical Journal, 320, pp. 1647–1651. doi: 10.1136/bmj.320.7250.1647.
